TEE
SPPI

Tibra Equities Europe’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Tibra Equities Europe’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-63,200
Closed -$676K – 471
2019
Q1 		$676K Buy
+63,200
New +$677K 0.07% 228

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tibra Equities Europe's SPPI Position: Q2 2019 in Review

Tibra Equities Europe sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 63,200 shares — an estimated $676K sold.

Tibra Equities Europe first reported a position in SPPI in Q1 2019 and held it in 1 quarter. The position peaked at $676K in Q1 2019. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

  • Tibra Equities Europe reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 63,200 Spectrum Pharmaceuticals Inc shares in Q2 2019, an estimated $676K.
  • Tibra Equities Europe first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Spectrum Pharmaceuticals Inc position peaked at $676K in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.